Integrative Approaches for Breast Cancer Survivorship
Integrative Approaches for Cancer Survivorship: A Multi-Site Feasibility and Acceptability Study
This project explores new ways to help breast cancer survivors manage challenges after treatment using personalized mind-body practices and health education.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11110418 on NIH RePORTER |
What this research studies
Many breast cancer survivors face ongoing difficulties with their quality of life after treatment, including issues like fatigue, sleep problems, and mood changes. This project aims to offer safe and effective solutions by testing two integrative medicine approaches. One approach is a personalized mind-body program based on Ayurvedic Medicine, which includes nutrition and lifestyle guidance. The other is a comprehensive health education program based on national guidelines for cancer survivorship. We want to see if these programs are practical and well-received by survivors across multiple locations.
Who could benefit from this research
Good fit: Ideal candidates for this type of research are individuals who have completed breast cancer treatment and are now navigating the survivorship phase.
Not a fit: Patients currently undergoing active cancer treatment or those without a breast cancer diagnosis would not be the focus of this particular research.
Why it matters
Potential benefit: If successful, this work could lead to new, widely available programs that significantly improve the quality of life for breast cancer survivors by addressing common post-treatment challenges.
How similar studies have performed: Prior single-site research has shown that these integrative interventions are feasible and acceptable, with the Ayurvedic approach showing promise for improving global health, sleep, fatigue, and mood.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Dhruva, Anand — University of California, San Francisco
- Study coordinator: Dhruva, Anand
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.